Neuroptix Raises $18.5 Million for Alzheimer’s Eye Test
Neuroptix Corp., an Acton, Mass.-based developer of a non-invasive eye test for early detection of Alzheimer’s Disease, has raised $18.5 million in Series B funding. Inventages led the round, while Rockport Venture Partners served as placement agent.
22 October 2008•3 mins read
